Starting to read the February Antimicrobial Resistance Benchmark (https://accesstomedicinefoundation.org/publications/2019-methodology-for-the-2020-antimicrobial-resistance-benchmark) the following citation directly hits me:
“In recent decades, AMR has become widespread, irrespective of national income levels. In Europe, drug-resistant bacteria are responsible for more than 670,000 infections and 33,000 deaths annually, costing EUR 1 billion in annual healthcare expenditure. Each year in the US, at least 2 million people get an antibacterial-resistant infection leading to at least 23,000 deaths. This costs over USD 20 billion in direct health care costs and as much as USD 35 billion in lost productivity.”
Continue reading “Age and the risk of resistant pathogens”